Efavirenz decreases etonogestrel exposure: a pharmacokinetic evaluation of implantable contraception with antiretroviral therapy

OBJECTIVES: The primary objective of this study was to characterize the pharmacokinetics of etonogestrel (ENG) released from a contraceptive implant in Ugandan women living with HIV who were receiving efavirenz (EFV)- or nevirapine (NVP)-based antiretroviral therapy (ART), compared to ART-naïve wome...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:AIDS
Main Authors: CHAPPELL, Catherine A., LAMORDE, Mohammed, NAKALEMA, Shadia, CHEN, Beatrice A., MACKLINE, Hope, RIDDLER, Sharon A., COHN, Susan E., DARIN, Kristin M., ACHILLES, Sharon L., SCARSI, Kimberly K.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5578871/
https://ncbi.nlm.nih.gov/pubmed/28692531
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0000000000001591
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados